Fiduciary Management Inc. WI, a hedge fund, has decreased its stock position in Fresenius Medical Care AG (NYSE:FMS) by 6.9% during the fourth quarter. The fund sold 417,637 shares, leaving it with 5,673,413 shares, valued at $118,177,000 at the end of the quarter. Other hedge funds have also made changes to their holdings of the company. Analysts have given FMS an average rating of 'Hold' with an average target price of $32.25. The company's stock traded at $21.09 on Monday, with a 50-day moving average of $20.56 and a 200-day moving average of $20.25. FMS reported earnings per share of $0.36 for the last quarter, beating the consensus estimate of $0.26. The company paid an annual dividend of $0.437 per share on June 3rd, representing a dividend yield of 2.35%. The ex-dividend date was May 17th. FMS has a market capitalization of $12.38 billion and a P/E ratio of 23.70. It is a provider of dialysis and related services for individuals with renal diseases [c35eafa1][MarketBeat].
The reduction in stock position by Fiduciary Management Inc. WI indicates a change in their investment strategy regarding Fresenius Medical Care AG. This could be due to various factors, such as a reassessment of the company's financial performance or a reallocation of funds to other investments. The average rating of 'Hold' by analysts suggests a neutral outlook for the stock, while the beating of earnings estimates in the last quarter indicates positive financial performance. The annual dividend payment and the company's focus on providing dialysis and related services for individuals with renal diseases contribute to its overall market perception [c35eafa1][MarketBeat].